December 2, 2021
House Committee on Energy and Commerce Health Subcommittee hearing on “THE OVERDOSE CRISIS: INTERAGENCY PROPOSAL TO COMBAT ILLICIT FENTANYL-RELATED SUBSTANCES”
Congresswoman Barragan asked questions of
Kemp L. Chester
Assistant Director
Executive Office of the President
Office of National Drug Control Policy
and
Nora D. Volkow, M.D.
Director, National Institute on Drug Abuse
National Institutes of Health